BERLIN, June 4, 2026 /PRNewswire/ -- Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it developed a Research Use Only (RUO) molecular PCR test, via its subsidiary TIB MOLBIOL, for use on the ...

Add Yahoo as a preferred source to see more of our stories on Google. The Bundibugyo virus is a rare Ebola species. Credit: QINQIE99 / Shutterstock.com. (QINQIE99 / Shutterstock.com.) Roche has ...

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak in central Africa. The diagnostics giant said it ...

Labcorp Holdings Inc (NYSE:LH) is reportedly collaborating with U.S. health regulators to determine whether it should scale up its mpox testing capabilities, following global concerns over a newly ...

This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...

New Roche test targeting detection of Bundibugyo virus supports efforts to address critical need during ongoing outbreaks1 Roche's unique outbreak response capabilities enabled rapid development of ...